Cleveland Clinic and IBM have announced the debut of the first on-site quantum computer in the US managed by a private company. This quantum computer, the IBM Quantum System One, will be dedicated exclusively to healthcare research, making it the world’s first quantum computer. The deployment of this quantum computer at Cleveland Clinic is expected to assist in the acceleration of biomedical discoveries.
IBM is a global hybrid cloud and AI solution provider for clients in over 175 countries. Their services help clients make informed decisions based on data, improve business processes, reduce costs, and achieve a competitive advantage. IBM’s hybrid cloud platform and Red Hat OpenShift are relied upon by nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications, and healthcare.
Their breakthrough innovations in AI, quantum computing, industry-specific cloud solutions, and business services offer flexible and open options to clients. IBM is committed to trust, transparency, responsibility, inclusivity, and service.
Quantum Computing provides aid in the Healthcare Industry.
The Discovery Accelerator, which functions as the technological base for the Global Center for Pathogen & Human Health Research at Cleveland Clinic’s Innovation District, has been unveiled. The center, funded by a $500 million investment from the State of Ohio, Jobs Ohio, and Cleveland Clinic, brings together experts dedicated to studying, preparing for, and safeguarding against emerging pathogens and virus-related diseases.
With the aid of advanced computational technology available through the Discovery Accelerator, researchers are accelerating their investigations into the development of treatments and vaccines.
Utilization of Hybrid Cloud and Artificial Intelligence for Health Research Projects
The collaboration between Cleveland Clinic and IBM in the Discovery Accelerator utilizes cutting-edge computing technologies such as hybrid cloud and artificial intelligence. The two organizations are working closely on various research projects to generate and analyze vast amounts of data for enhancing research.
Several projects have been initiated in the Cleveland Clinic-IBM Discovery Accelerator, which utilizes the latest in quantum computing, AI, and hybrid cloud technologies to accelerate discoveries in biomedical research. These include the development of quantum computing pipelines for drug screening and optimization, an improved quantum-enhanced prediction model for assessing cardiovascular risk after non-cardiac surgery, and the application of AI to search genome sequencing findings and drug-target databases for identifying existing drugs that could potentially treat Alzheimer’s and other diseases.
“This is a pivotal milestone in our innovative partnership with IBM, as we explore new ways to apply the power of quantum computing to healthcare. This technology holds tremendous promise in revolutionizing healthcare and expediting progress toward new cares, cures and solutions for patients. Quantum and other advanced computing technologies will help researchers tackle historic scientific bottlenecks and potentially find new treatments for patients with diseases like cancer, Alzheimer’s and diabetes.”
Tom Mihaljevic, M.D., Cleveland Clinic CEO and President and Morton L. Mandel CEO Chair.
A crucial partnership aspect involves educating the future workforce and generating employment opportunities to expand the economy. An inventive academic curriculum is being developed for individuals ranging from high school students to professionals, providing instruction and certification courses in data science, machine learning, and quantum computing. These programs are designed to cultivate a qualified workforce capable of carrying out advanced computational research in the future.
Furthermore, both organizations conduct research symposia, seminars, and workshops for academia, industry, government, and the general public. The objective is to assemble a substantial number of computing experts in Cleveland.
“With the unveiling of IBM Quantum System One at Cleveland Clinic, their team of world-class researchers can now explore and uncover new scientific advancements in biomedical research. By combining the power of quantum computing, artificial intelligence and other next-generation technologies with Cleveland Clinic’s world-renowned leadership in healthcare and life sciences, we hope to ignite a new era of accelerated discovery.”
Arvind Krishna, IBM Chairman and CEO.
About Cleveland Clinic
Cleveland Clinic is a well-known nonprofit medical center founded in 1921 in Cleveland, Ohio. The center has a long history of pioneering medical breakthroughs and providing outstanding patient care. Its staff includes over 5,600 salaried physicians, researchers, 19,000 registered nurses, and advanced practice providers, representing 140 medical specialties and subspecialties.
Cleveland Clinic operates a 6,665-bed health system with a 173-acre main campus near downtown Cleveland, 22 hospitals, and more than 275 outpatient facilities in locations such as northeast Ohio, southeast Florida, Las Vegas, Toronto, Abu Dhabi, and London. In 2022, Cleveland Clinic had 12.8 million outpatient encounters, 303,000 hospital admissions and observations, and 270,000 surgeries and procedures, with patients coming from every state in the US and 185 countries.
Read more about it here.